Search research articles
Contact Us
Filters
Showing results (321-330 of 453) with videos related to
Page
of 46
Sort By:
Neuro-Oncology Advances
|
May 11, 2022
Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT)
Heather E Leeper, Emily Tonorezos, Deborah Mayer, et al.
Cancers
|
December 10, 2021
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas
Guangyang Yu, Ying Pang, Mythili Merchant, et al.
Neuro-Oncology Practice
|
December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525
H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
The Lancet. Oncology
|
November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada, Michael Weller, Raymond Huang, et al.
Neuro-Oncology Advances
|
February 23, 2023
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering
Brandon H Bergsneider, Elizabeth Vera, Ophir Gal, et al.
Neuro-Oncology Practice
|
February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations
Amanda L King, Kayla N Roche, Elizabeth Vera, et al.
Nature Communications
|
January 28, 2021
IDH1 mutations induce organelle defects via dysregulated phospholipids
Adrian Lita, Artem Pliss, Andrey Kuzmin, et al.
Neuro-Oncology Advances
|
October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop
Marta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Cancer & Metabolism
|
October 26, 2020
Metabolic plasticity of IDH1<i>-mutant</i> glioma cell lines is responsible for low sensitivity to glutaminase inhibition
Victor Ruiz-Rodado, Adrian Lita, Tyrone Dowdy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma
John H Sampson, Amy B Heimberger, Gary E Archer, et al.
Page
of 46
Search research articles
Search
Showing results (321-330 of 453) with videos related to
Sort By:
Page
of 46
Neuro-Oncology Advances
|
May 11, 2022
Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT)
Heather E Leeper, Emily Tonorezos, Deborah Mayer, et al.
Cancers
|
December 10, 2021
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas
Guangyang Yu, Ying Pang, Mythili Merchant, et al.
Neuro-Oncology Practice
|
December 14, 2019
The association between BMI and BSA-temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525
H Ian Robins, Jens Eickhoff, Mark R Gilbert, et al.
The Lancet. Oncology
|
November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada, Michael Weller, Raymond Huang, et al.
Neuro-Oncology Advances
|
February 23, 2023
Discovery of clinical and demographic determinants of symptom burden in primary brain tumor patients using network analysis and unsupervised clustering
Brandon H Bergsneider, Elizabeth Vera, Ophir Gal, et al.
Neuro-Oncology Practice
|
February 7, 2025
The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations
Amanda L King, Kayla N Roche, Elizabeth Vera, et al.
Nature Communications
|
January 28, 2021
IDH1 mutations induce organelle defects via dysregulated phospholipids
Adrian Lita, Artem Pliss, Andrey Kuzmin, et al.
Neuro-Oncology Advances
|
October 2, 2020
Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop
Marta Penas-Prado, Brett J Theeler, Brittany Cordeiro, et al.
Cancer & Metabolism
|
October 26, 2020
Metabolic plasticity of IDH1<i>-mutant</i> glioma cell lines is responsible for low sensitivity to glutaminase inhibition
Victor Ruiz-Rodado, Adrian Lita, Tyrone Dowdy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma
John H Sampson, Amy B Heimberger, Gary E Archer, et al.
Page
of 46